Summary
A sample labeled as Cialis (Tadalafil) was analyzed by Janoshik Analytical to verify its composition and potency. The sample, identified by Task Number #49248, was submitted by asteroidbiotech@proton.me.
The analysis confirmed the presence of Tadalafil at 11.02 mg per unit, though the intended dosage is unknown due to the lack of a specified manufacturer or batch number.
The testing was ordered on 26 August 2024, with the sample received on 19 September 2024 and the final analysis conducted on 24 September 2024.
Detailed Report
Product Overview
- Manufacturer: Asteroidbiotech
- Product Name: Cialis
- Active Ingredient: Tadalafil
- Batch Number: Unknown
- Expiration Date: Not provided
- Delivery Method: Oral tablet
Testing Details
- Task Number: #49248
- Testing Ordered: 26 August 2024
- Sample Received: 19 September 2024
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Asteroidbiotech (manufacturer)
- Analysis Paid For By: Asteroidbiotech (manufacturer)
Testing Results
- Detected Compound: Tadalafil
- Measured Dosage: 11.02 mg per unit
- Labeled Dosage: Unknown
- Accuracy: Cannot be determined without a reference label claim
Verification Details
Verification URL: https://janoshik.com/tests/49248_FYJ5X2SHR3IQ
Evaluation of Manufacturer-Submitted Testing
The analysis confirmed that the Cialis sample contains Tadalafil at 11.02 mg per unit. However, due to the lack of a manufacturer, batch number, or labeled dosage, it is unclear whether this matches the intended pharmaceutical standard.
Cialis (Tadalafil) is a PDE5 inhibitor commonly used for erectile dysfunction and benign prostatic hyperplasia (BPH). While 10 mg is a standard therapeutic dose, inconsistencies in manufacturing or potential underdosing or overdosing can impact efficacy and safety.
Given the unknown source, consumers should exercise caution before using this product. Independent third-party testing across multiple samples is recommended to confirm product consistency.
Conclusion
The analysis confirms that the Cialis sample contains Tadalafil at 11.02 mg per unit. However, the lack of manufacturer information and batch details raises concerns about quality control and consistency.
Users should approach this product with caution and consider verifying dosages further before use.
This report is provided for educational and harm reduction purposes, ensuring consumers make informed decisions about pharmaceutical products.
Disclaimer
This report is published for informational and harm reduction purposes. The analysis was conducted on a single sample, and results may not reflect the consistency of future batches. Readers are encouraged to use this information responsibly.
